Revolutionary Cancer Treatment: Halda Therapeutics and Vantai Agree on $1 Billion AI-Powered Partnership
Halda Therapeutics and Vantai have partnered to develop AI-driven cancer treatments using induced proximity technology,…
Therapeutics
Abdera Therapeutics Unveils Promising Phase 1 Trial Results for ABD-147 at IASLC 2025 World Conference
Abdera Therapeutics presents early pharmacokinetics, dosimetry, and safety data from ongoing Phase 1 trial of…
Rakovina Therapeutics CSO Dr. Mads Daugaard to Present at Prestigious Cancer Research Retreat
Dr. Mads Daugaard, Chief Scientific Officer of Rakovina Therapeutics, has been invited to present at…
Eris Lifesciences Sees 31% Profit Surge, Driven by New Launches and Therapeutics
Eris Lifesciences reports a 31% increase in profit, reaching Rs 106 crore, driven by new…